Lyophilized MUST BE RECONSTITUTED

AOD 9604 is a breakthrough peptide developed in the 1990s to combat obesity. Scientific studies reveal its potential to enhance lipolysis—the breakdown of stored fats—by influencing fat cells and key receptors.

AOD 9604’s unique feature lies in its modified hGH portion, which may trigger significant fat burning without stimulating Insulin-like Growth Factor IGF-1. Step into the future of weight management with AOD 9604—a cutting-edge solution at the forefront of targeted fat reduction in research.